Earnings Feed
Start Free
Home/Filings/4/0001127602-16-065433
4//SEC Filing

HAEMONETICS CORP 4

Accession 0001127602-16-065433

$HAECIK 0000313143operating
View on SEC.govCompany Profile

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 7:56 PM ET

Size

9.7 KB

Accession

0001127602-16-065433

Insider Transaction Report

Form 4
Period: 2016-10-25
HAEMONETICS CORPHAE
Jesse Sandra
VP & CLO
Transactions
  • Award

    Non-qualified Stock Option (Right to Buy)

    2016-10-25$3421.00/sh+14,187$48,533,727→ 14,187 total
    Exercise: $34.21From: 2017-10-25Exp: 2023-10-25→ Common Stock (14,187 underlying)
  • Award

    Performance Shares

    2016-10-25+6,577→ 6,577 total
    Exercise: $0.00From: 2019-09-30Exp: 2019-12-31→ Common Stock (6,577 underlying)
  • Award

    Common Stock

    2016-10-25$34.21/sh+3,288$112,482→ 48,166 total
Footnotes (3)
  • [F1]Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
  • [F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
  • [F3]Performance Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Performance Share Unit based on the performance of Haemonetics stock price relative to the Total Shareholder Return of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600. The number of Performance Share Units (and therefore the number of shares payable) will depend on the Company's stock price performance between October 1, 2016 and September 30, 2019. The Performance Share Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to twice the target amount in column 5. The Performance Share Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).

Documents

1 file

Issuer

HAEMONETICS CORP

CIK 0000313143

→
Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000313143

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 7:56 PM ET
Size
9.7 KB
View on SEC.gov